Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
---|
07/30/2003 | EP1330458A1 N-( 1,2,4]triazoloazinyl) thiophenesulfonamide compounds as herbicides |
07/30/2003 | EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
07/30/2003 | EP1330233A1 Method of treating stroke |
07/30/2003 | CN1433411A Chemical compounds |
07/30/2003 | CN1433396A Pharmaceutical compounds |
07/30/2003 | CN1432873A Acid generating agent, sulfonic acid, sulfonic acid and radiation-sensitive resin composition |
07/30/2003 | CN1432562A Intermediate product for preparing benzamidoxime derivative |
07/30/2003 | CN1116294C Synthesis of 3-carbomethoxy-4,5-dimethylthiophene |
07/30/2003 | CN1116277C Process for preparing carbocylic or heterocyclic nitriles by vapor phase ammoxidation |
07/30/2003 | CN1116271C Method of producing 2-substituted-3,4-fused heterocycle benzoic acid |
07/29/2003 | US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
07/29/2003 | US6600052 With a ring cyclizing reagent to form the compound of Formula V to yield a compound of Formula V: inhibitors of the cyclooxygenase- II enzyme. and antiinflammatory agents and analgesic pharmaceutical agents. |
07/29/2003 | US6599943 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase |
07/29/2003 | US6599934 3,4-diaryl thiopenes and analogs thereof having use as antiinflammatory agents |
07/29/2003 | US6599932 Highly selective in killing tumor cells but not normal cells |
07/29/2003 | US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
07/29/2003 | US6599648 Heterarylbenzene compounds |
07/29/2003 | CA2123514C Novel benzothiophene derivative |
07/24/2003 | WO2003059900A1 Coumarin derivatives, process for their production and use thereof |
07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
07/24/2003 | WO2003059874A2 Aromatic thioether liver x-receptor modulators |
07/24/2003 | WO2003059335A1 Phenyl sulfoxides and phenyl sulfones |
07/24/2003 | WO2003059258A2 Compositions and methods for treating heart failure |
07/24/2003 | WO2003059064A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives |
07/24/2003 | WO2003046200A3 Methods for ligand discovery |
07/24/2003 | US20030139475 Novel tricyclic compounds and drug compositions containing same |
07/24/2003 | US20030139457 Small organic molecule regulators of cell proliferation |
07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
07/24/2003 | US20030139421 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
07/24/2003 | US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders |
07/24/2003 | US20030137240 Di(het)arylaminothiophene derivatives |
07/24/2003 | CA2473374A1 Phenyl sulfoxides and phenyl sulfones |
07/24/2003 | CA2472419A1 Coumarin derivatives, process for their production and use thereof |
07/24/2003 | CA2471311A1 Aromatic thioether liver x-receptor modulators |
07/23/2003 | EP1328521A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
07/23/2003 | EP1328508A2 Propionic acid derivatives with ppar-alpha activating properties |
07/23/2003 | EP1025083B1 Process for stereoselective synthesis of prostacyclin derivatives |
07/23/2003 | CN1431941A 挤压模 Extrusion die |
07/23/2003 | CN1431208A Process for prepn. of 5-hydroxybenz [b] thiofuran-3-carboxylic acid derivative |
07/22/2003 | US6596873 2-and 2,5-substituted phenylketoenols |
07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
07/22/2003 | US6596756 Treatment of fibromyalgia |
07/22/2003 | US6596754 Preventives/remedies for multiple organ failure |
07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
07/22/2003 | US6596743 Carbamic acid derivatives |
07/22/2003 | US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders. |
07/22/2003 | US6596716 2-propane-sulphonamide derivatives |
07/22/2003 | CA2245250C Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
07/17/2003 | WO2003057661A1 Prodrugs of excitatory amino acids |
07/17/2003 | WO2003057254A1 Preventives/remedies for urinary disturbance |
07/17/2003 | WO2003057225A2 Phosphate transport inhibitors |
07/17/2003 | WO2003057169A2 4-dedimethylamino tetracycline compounds |
07/17/2003 | WO2003029188A3 Beta-substituted nitrostyrene and cyanostyrene compounds and their use as nematicides and fungicides |
07/17/2003 | US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics |
07/17/2003 | US20030135045 Glycoprotein IIb/IIIa antagonists |
07/17/2003 | US20030135021 Optically active polythiophenes |
07/17/2003 | US20030134880 Novel cd23 inhibitors |
07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
07/17/2003 | US20030134227 New photoacid generator compounds ("PAGs") are provided and photoresist compositions that comprise such compounds. In particular, cyclic sulfonium and sulfoxonium PAGs are provided. PAGs of the invention are particularly useful as |
07/17/2003 | US20030131422 Primary intermediates for oxidative coloration of hair |
07/17/2003 | CA2471760A1 Preventives/remedies for urinary disturbance |
07/16/2003 | EP1327636A2 Heterocyclic metallocenes and polymerisation catalysts |
07/16/2003 | EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
07/16/2003 | EP1326993A2 PRODUCTION OF g(a)-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
07/16/2003 | EP1326827A2 Insecticidal 1,8-naphthalenedicarboxamides |
07/16/2003 | EP1326824A1 Pharmaceutical compounds |
07/16/2003 | CN1430603A Novel bicyclic compounds |
07/16/2003 | CN1430596A New gamma selective retinoids |
07/16/2003 | CN1114602C Ketone derivatives and medicinal use thereof |
07/15/2003 | US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes |
07/15/2003 | US6593374 Such as 3-(3'4'5'-trimethoxybenzoyl)-2-(3'benzylphosphate 4'methoxyphenyl)-6-methoxybenzo(b)thiophene; functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates useful as antitumor agents |
07/15/2003 | US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis |
07/15/2003 | US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery |
07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
07/15/2003 | US6592631 Useful as developer compounds in oxidation dye compositions for keratin fibers. |
07/15/2003 | CA2238465C Triaromatic compounds, compositions containing them and uses |
07/15/2003 | CA2218766C Bicyclic-aromatic compounds |
07/10/2003 | WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
07/10/2003 | WO2003055848A2 Urea derivatives as vr1- antagonists |
07/10/2003 | WO2003055847A1 Carboxylic acid derivative |
07/10/2003 | WO2003055484A1 Urea derivatives |
07/10/2003 | WO2003055479A1 Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3 |
07/10/2003 | WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
07/10/2003 | WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
07/10/2003 | WO2001098248A3 Hiv integrase inhibitors |
07/10/2003 | WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
07/10/2003 | US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
07/10/2003 | US20030130511 Replacing a halogen atom with an electrophilic group (e.g., a formyl group) using either a mixture of an organomagnesium halide and an alkyllithium or a reaction product of the two, such as trialkylmagnesium lithium |
07/10/2003 | US20030130456 Vinyl group-containing diarylethene and polymer thereof having excellent optical properties |
07/10/2003 | US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion |
07/10/2003 | US20030130345 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals |
07/10/2003 | US20030130342 Such as anticoagulant 3-(6-(4-(aminoiminomethyl)phenyl methoxy)-2-methyl-2H-1-benzopyran-2-yl)propanoic acid hydrochloride |
07/10/2003 | US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents |
07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
07/10/2003 | US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators |
07/10/2003 | US20030130258 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
07/10/2003 | US20030130239 Vision defects |